News | Ultrasound Imaging | April 30, 2018

Esaote Change of Ownership Completed

Biomedical equipment company’s share capital purchased by consortium of Chinese investors

Esaote Change of Ownership Completed

April 30, 2018 — The acquisition of biomedical equipment company Esaote SpA’s share capital was completed on April 19, the company recently announced, by a consortium of leading Chinese investors. The consortium is composed of major companies in the medical and healthcare technology sectors, as well as investment funds with significant experience in this field.

As a result of this change in ownership, Esaote said it will be in a stronger position and have the opportunity to accelerate its development plans, and in particular its growth projects in China. In addition to its current worldwide presence, Esaote said it will also benefit from the widespread distribution networks of the new shareholders, and from the distribution of the consortium’s main products in the international markets in which Esaote operates.

The consortium is composed of:

  • Private equity fund Yufeng Capital;
  • Wandong, China’s largest listed medical equipment manufacturer;
  • Shanghai FTZ Fund, China’s first Free Trade Zone fund;
  • Tianyi, an investment group focused on the healthcare sector;
  • Yuyue, the holding company of the largest homecare medical equipment manufacturer in China; and
  • Kangda, OEM manufacturer and distributor of medical imaging equipment.

Under the agreement — whose terms and conditions remain as announced on Dec. 7, 2017 — Esaote will continue to operate as an independent international company, with its headquarters in Genoa, Italy, and research and development and production centers in Italy and the Netherlands.

For more information: www.esaote.com

 

Related Content

CMS Proposes New Alternative Payment Model for Radiation Oncology
News | Radiation Oncology | July 17, 2019
The Centers for Medicare and Medicaid Services (CMS) issued a proposal for an advanced alternative payment model (APM)...
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity.

Routine scan of abdomen pelvis taken with the UW-Madison’s Revolution 256 CT scanner using the FDA-cleared reconstruction algorithm, called TrueFidelity. UW-Madison was the first site in the U.S. to get this technology. Its use is now being integrated into UW CT protocols. Image courtesy of Timothy P. Szczykutowicz

Feature | Computed Tomography (CT) | July 12, 2019 | By Greg Freiherr
When providers develop their own imaging protocols, they are wasting time and money, according to...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
360 Photos | Ultrasound Imaging | July 11, 2019
This 360 degree photo shows a basic, point-of-care cardiac echocardiogram being performed using a smartphone turned i
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
360 Photos | Ultrasound Imaging | July 09, 2019
A view of a mitral valve on a GE Healthcare Vivid E95 ...
360 Photos | Ultrasound Imaging | July 08, 2019
This is a 360 degree view of a live cardiac echo demonstration for the Siemens Healthineers Acuson SC2000...